Rabbit Recombinant Monoclonal DMGDH antibody. Suitable for WB and reacts with Mouse, Rat, Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | |
---|---|
Human | Tested |
Mouse | Tested |
Rat | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 | Notes - |
Species Rat | Dilution info 1/1000 | Notes - |
Species Human | Dilution info 1/1000 | Notes - |
Select an associated product type
Catalyzes the demethylation of N,N-dimethylglycine to sarcosine. Also has activity with sarcosine in vitro.
ME2GLYDH, DMGDH
Rabbit Recombinant Monoclonal DMGDH antibody. Suitable for WB and reacts with Mouse, Rat, Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
DMGDH also known as dimethylglycine dehydrogenase is a mitochondrial enzyme with a mass of approximately 103 kDa. This protein is expressed predominantly in liver and kidney tissues. DMGDH plays an important role in the degradation of choline where it catalyzes the oxidative demethylation of dimethylglycine into sarcosine while producing formaldehyde and hydrogen peroxide. This process is an important step in the choline oxidation pathway which helps maintain the methylation balance in the cell.
DMGDH contributes to the one-carbon metabolism pathway which involves the transfer of one-carbon units essential for various biosynthetic reactions. It does not form part of a larger enzymatic complex but operates as an independent enzyme within the mitochondrial matrix. Its activity is important for methyl cycle function influencing processes like nucleotide synthesis and amino acid metabolism. The enzyme helps connect choline metabolism to broader metabolic networks impacting cellular methyl group availability.
DMGDH is integral to the choline metabolism pathway and the one-carbon metabolic pathway. Choline is oxidized to produce substrates for the methionine cycle affecting homocysteine levels and S-adenosylmethionine production. DMGDH's function is closely linked to other enzymes like dimethylglycine N-methyltransferase (DNMT) which also engages in methyl group transfer. Together these enzymes collaborate to maintain cellular methylation and detoxification pathways.
DMGDH dysfunction has been associated with metabolic conditions such as homocystinuria and cardiovascular disease. Impaired DMGDH activity can lead to increased levels of dimethylglycine which in turn may disrupt methylation balance and contribute to metabolic abnormalities. While DMGDH does not directly interact with any known disease-specific proteins its role in maintaining proper methylation highlights its importance in disease pathology. By influencing levels of substrates like homocysteine DMGDH indirectly connects to disorders linked to methylation dysregulation.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking/Dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-DMGDH antibody [EPR16907] (ab199534) at 1/1000 dilution
All lanes: Human fetal liver tissue lysate at 10 µg
All lanes: Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 34 kDa, 36 kDa, 97 kDa
Observed band size: 97 kDa
Exposure time: 3min
Blocking/Dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-DMGDH antibody [EPR16907] (ab199534) at 1/1000 dilution
All lanes: Human fetal kidney lysate at 10 µg
All lanes: Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 97 kDa
Observed band size: 97 kDa
Exposure time: 1min
Blocking/Dilution buffer: 5% NFDM/TBST.
All lanes: Western blot - Anti-DMGDH antibody [EPR16907] (ab199534) at 1/1000 dilution
Lane 1: Mouse kidney lysate at 10 µg
Lane 2: Mouse spleen lysate at 10 µg
Lane 3: Rat kidney lysate at 10 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Exposure time: 3min
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com